Skip to main content
Year archive

Evogene Ltd. — 2020 filings

All 146 regulatory filings released by Evogene Ltd. (EVGN) in 2020, sourced directly from the official regulator.

146 Filings
2020 Period
2020 filings (146)
Filing Released Lang
Changes in management
Board/Management Information
2020-12-31 English
Changes in management
Board/Management Information
2020-12-31 English
6-K
Foreign Filer Report
2020-12-31 English
Lavie Bio Provides Product Pipeline Update for 2020
Regulatory Filings
2020-12-29 English
Lavie Bio Provides Product Pipeline Update for 2020
Report Publication Announcement
2020-12-29 English
6-K
Foreign Filer Report
2020-12-29 English
Signing of First Cultivation Agreement for its Medical Cannabis Varieties
Regulatory Filings
2020-12-23 English
Signing of First Cultivation Agreement for its Medical Cannabis Varieties
Report Publication Announcement
2020-12-23 English
6-K
Foreign Filer Report
2020-12-23 English
AgPlenus Announces Reaching a ‘Lead’ Stage in its Novel Mode-of-Action Herbicide Program
Regulatory Filings
2020-12-15 English
AgPlenus Announces Reaching a ‘Lead’ Stage in its Novel Mode-of-Action Herbicide Program
Report Publication Announcement
2020-12-15 English
6-K
Foreign Filer Report
2020-12-15 English
Mr. Gadi Ben Nissim will conclude his position as Evogene’s Executive Vice President Corporate Development
Board/Management Information
2020-12-10 English
Mr. Gadi Ben Nissim will conclude his position as Evogene’s Executive Vice President Corporate Development
Board/Management Information
2020-12-10 English
6-K
Foreign Filer Report
2020-12-10 English
Financial Results for the Third Quarter of 2020
Interim / Quarterly Report Q3 2020
2020-11-18 Hebrew (modern)
Financial Results for the Third Quarter of 2020
Report Publication Announcement
2020-11-18 English
Reports Third Quarter 2020 Financial Results
Interim / Quarterly Report Q3 2020
2020-11-18 English
Reports Third Quarter 2020 Financial Results
Report Publication Announcement
2020-11-18 English
6-K
Foreign Filer Report
2020-11-18 English
Announces Closing of $12 Million Registered Direct Offering
Share Issue/Capital Change
2020-11-04 English
Announces Closing of $12 Million Registered Direct Offering
Capital/Financing Update
2020-11-04 English
SCHEDULE 13G-Alpha Capital Anstalt
Major Shareholding Notification
2020-11-03 English
SCHEDULE 13G-Alpha Capital Anstalt
Major Shareholding Notification
2020-11-03 English
Prospectus Supplement Dated October 30, 2020
Capital/Financing Update
2020-11-03 English
Prospectus Supplement Dated October 30, 2020
Regulatory Filings
2020-11-03 English
424B5
Prospectus
2020-11-02 English
AMENDMENT NO. 1 TO SCHEDULE 13G
Major Shareholding Notification
2020-11-02 English
Financial Results and Earnings Announcement Schedule for the Third Quarter of 2020
Earnings Release Q3 2020
2020-11-02 English
Financial Results and Earnings Announcement Schedule for the Third Quarter of 2020
Earnings Release Q3 2020
2020-11-02 English
6k-Prices $12 Million Registered Direct Offering
Regulatory Filings
2020-10-31 English
6k-Prices $12 Million Registered Direct Offering
Report Publication Announcement
2020-10-31 English
6-K
Foreign Filer Report
2020-10-30 English
Prices $12 Million Registered Direct Offering
Share Issue/Capital Change
2020-10-30 English
Prices $12 Million Registered Direct Offering
Report Publication Announcement
2020-10-30 English
positive results for LAV311 and LAV312 in the bio-fungicide program of its subsidiary, Lavie Bio Ltd
Regulatory Filings
2020-10-29 English
positive results for LAV311 and LAV312 in the bio-fungicide program of its subsidiary, Lavie Bio Ltd
Report Publication Announcement
2020-10-29 English
6-K
Foreign Filer Report
2020-10-29 English
Results of 2020 Annual General Meeting of Shareholders
Declaration of Voting Results & Voting Rights Announcements
2020-10-20 English
Results of 2020 Annual General Meeting of Shareholders
Report Publication Announcement
2020-10-20 English
6-K
Foreign Filer Report
2020-10-20 English
Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program
Regulatory Filings
2020-10-13 English
Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program
Regulatory Filings
2020-10-13 English
6-K
Foreign Filer Report
2020-10-13 English
Schedule 13G -ARK Investment Management
Major Shareholding Notification
2020-10-11 English
Schedule 13G -ARK Investment Management
Regulatory Filings
2020-10-11 English
Schedule 13G - Alpha Capital
Major Shareholding Notification
2020-10-11 English
Schedule 13G - Alpha Capital
Major Shareholding Notification
2020-10-11 English
SC 13G
Major Shareholding Notification
2020-10-09 English
CANONIC-COMPANY PRESENTATION
Investor Presentation
2020-09-17 English
CANONIC-COMPANY PRESENTATION
Report Publication Announcement
2020-09-17 English
6-K
Foreign Filer Report
2020-09-17 English
6K: 6 months financial statements & MD&A
Interim / Quarterly Report H1 2020
2020-09-16 English
6K: 6 months financial statements & MD&A
Report Publication Announcement H1 2020
2020-09-16 English
6-K
Foreign Filer Report
2020-09-15 English
NOTICE OF 2020 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 19, 2020
Proxy Solicitation & Information Statement
2020-09-10 English
NOTICE OF 2020 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 19, 2020
AGM Information
2020-09-10 English
NOTICE OF 2020 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON OCTOBER 19, 2020
AGM Information
2020-09-10 English
6-K
Foreign Filer Report
2020-09-10 English
Evogene Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
Report Publication Announcement
2020-09-09 English
Evogene Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
Report Publication Announcement
2020-09-09 English
Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program
Regulatory Filings
2020-09-08 English
Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program
Report Publication Announcement
2020-09-08 English
6-K
Foreign Filer Report
2020-09-08 English
Prospectus Supplement Dated September 1, 2020
Capital/Financing Update
2020-09-03 English
Prospectus Supplement Dated September 1, 2020
Regulatory Filings
2020-09-03 English
424B5
Prospectus
2020-09-02 English
Evogene Announces $10 Million Equity Investment led by ARK Investment Management, LLC
Regulatory Filings
2020-09-02 English
Evogene Announces $10 Million Equity Investment led by ARK Investment Management, LLC
Report Publication Announcement
2020-09-02 English
6-K
Foreign Filer Report
2020-09-02 English
SCHEDULE 13G
Major Shareholding Notification
2020-09-01 English
Announces $10 Million Equity Investment led by ARK Investment Management, LLC
Capital/Financing Update
2020-09-01 English
Announces $10 Million Equity Investment led by ARK Investment Management, LLC
Share Issue/Capital Change
2020-09-01 English
Changes in Management
Board/Management Information
2020-09-01 English
Changes in Management
Board/Management Information
2020-09-01 English
6-K
Foreign Filer Report
2020-09-01 English
Evogene to Present at on Wednesday, September 2l Conference
Report Publication Announcement
2020-08-19 English
Evogene to Present at on Wednesday, September 2l Conference
Report Publication Announcement
2020-08-19 English
Regulatory Filings 2020
Regulatory Filings
2020-08-11 English
Regulatory Filings 2020
Regulatory Filings
2020-08-06 English
Regulatory Filings 2020
Regulatory Filings
2020-08-06 English
Reports Second Quarter 2020 Financial Results
Earnings Release Q2 2020
2020-08-05 English
Reports Second Quarter 2020 Financial Results
Report Publication Announcement
2020-08-05 English
6K-Changes in Management
Board/Management Information
2020-08-05 English
6K-Changes in Management
Board/Management Information
2020-08-05 English
6-K
Foreign Filer Report
2020-08-05 English
6-K
Foreign Filer Report
2020-08-05 English
FORM F-3-REGISTRATION STATEMENT,SUBJECT TO COMPLETION, DATED JULY 31, 2020
Capital/Financing Update
2020-08-01 English
FORM F-3-REGISTRATION STATEMENT,SUBJECT TO COMPLETION, DATED JULY 31, 2020
Report Publication Announcement
2020-08-01 English
F-3
Regulatory Filings
2020-07-31 English
to Present at Jefferies Virtual 2020 Industrials Conference
Report Publication Announcement
2020-07-29 English
to Present at Jefferies Virtual 2020 Industrials Conference
Report Publication Announcement
2020-07-29 English
Evogene will release its financial results for the second quarter 2020 on Wednesday, August 5, 2020
Earnings Release Q2 2020
2020-07-15 English
Evogene will release its financial results for the second quarter 2020 on Wednesday, August 5, 2020
Report Publication Announcement
2020-07-15 English
Evogene to Participate in CRISPR-IL Consortium to Provide end-to-end Artificial Intelligence System for Genome-Editing
Regulatory Filings
2020-06-03 English
Evogene to Participate in CRISPR-IL Consortium to Provide end-to-end Artificial Intelligence System for Genome-Editing
Regulatory Filings
2020-06-03 English
Changes in subsidiary management
Board/Management Information
2020-05-28 English
Changes in subsidiary management
Report Publication Announcement
2020-05-28 English
6-K
Foreign Filer Report
2020-05-28 English
Evogene Reports First Quarter 2020 Financial Results
Interim / Quarterly Report Q1 2020
2020-05-26 English
Evogene Reports First Quarter 2020 Financial Results
Report Publication Announcement
2020-05-26 English
6-K
Foreign Filer Report
2020-05-26 English
Evogene Launches its New Branding to Reflect the Company's Expanded Vision and New Business Model
Investor Presentation
2020-05-20 English
Evogene Launches its New Branding to Reflect the Company's Expanded Vision and New Business Model
Report Publication Announcement
2020-05-20 English
6-K
Foreign Filer Report
2020-05-20 English
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2020
Report Publication Announcement
2020-05-07 English
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2020
Report Publication Announcement
2020-05-07 English
changes in its management
Board/Management Information
2020-05-06 English
changes in its management
Board/Management Information
2020-05-06 English
6-K
Foreign Filer Report
2020-05-06 English
CEO Letter to Shareholders
Regulatory Filings
2020-05-05 English
CEO Letter to Shareholders
Report Publication Announcement
2020-05-05 English
6-K
Foreign Filer Report
2020-05-05 English
Evogene Files Annual Report for the Year Ended 31.12.19
Report Publication Announcement FY 2019
2020-04-30 English
Evogene Files Annual Report for the Year Ended 31.12.19
Report Publication Announcement FY 2019
2020-04-30 English
FORM 20-F For the fiscal year ended December 31, 2019
Annual Report FY 2019
2020-04-27 English
FORM 20-F For the fiscal year ended December 31, 2019
Report Publication Announcement
2020-04-27 English
20-F
Annual Report FY 2019
2020-04-27 English
Corteva Agriscience and AgPlenus Announce Collaboration for the Development of Novel Herbicides
Regulatory Filings
2020-03-25 English
Corteva Agriscience and AgPlenus Announce Collaboration for the Development of Novel Herbicides
Report Publication Announcement
2020-03-25 English
6-K
Foreign Filer Report
2020-03-25 English
Evogene Reports Fourth Quarter and Full Year 2019 Financial Results
Earnings Release Q4 2019
2020-03-04 English
Evogene Reports Fourth Quarter and Full Year 2019 Financial Results
Earnings Release FY 2019
2020-03-04 English
6-K
Foreign Filer Report
2020-03-04 English
Attend in Bank of America 2020 Global Agriculture and Materials Conference
Report Publication Announcement
2020-02-25 English
Attend in Bank of America 2020 Global Agriculture and Materials Conference
Regulatory Filings
2020-02-25 English
The Phoenix report on Schedule 13G filed with the SEC
Major Shareholding Notification
2020-02-19 English
The Phoenix report on Schedule 13G filed with the SEC
Regulatory Filings
2020-02-19 English
SC 13G/A
Major Shareholding Notification
2020-02-18 English
Waddell & Reed report on Schedule 13G filed with the SEC
Major Shareholding Notification
2020-02-16 English
Waddell & Reed report on Schedule 13G filed with the SEC
Major Shareholding Notification
2020-02-16 English
EVOGENE LTD
Major Shareholding Notification
2020-02-14 English
Evogene Financial Results for the Fourth Quarter and Full Year of 2019 Earnings Announcement Schedule
Earnings Release FY 2019
2020-02-12 English
Evogene Financial Results for the Fourth Quarter and Full Year of 2019 Earnings Announcement Schedule
Report Publication Announcement
2020-02-12 English
UBS report on Schedule 13G filed with the SEC
Major Shareholding Notification
2020-02-11 English
UBS report on Schedule 13G filed with the SEC
Report Publication Announcement
2020-02-11 English
SC 13G/A
Major Shareholding Notification
2020-02-11 English
SCHEDULE 13G/A
Major Shareholding Notification
2020-02-09 English
SCHEDULE 13G/A
Major Shareholding Notification
2020-02-09 English
SCHEDULE 13G
Major Shareholding Notification
2020-02-09 English
SCHEDULE 13G
Major Shareholding Notification
2020-02-09 English
EVOGENE LTD.
Major Shareholding Notification
2020-02-07 English
SC 13G
Major Shareholding Notification
2020-02-06 English
Evogene Investor Presentation – January 2020
Investor Presentation
2020-01-28 English
Evogene Investor Presentation – January 2020
Investor Presentation
2020-01-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2020-01-28 English